AzTrials
AzTrials

Knee OsteoarthritisNCT04665804

Effects of Creatine Supplementation as Compared to Glucosamine/Chondroitin Sulfate Supplementation in Addition to Exercise and Physical Therapy in the Management of Knee Osteoarthritis.

A study testing Creatine Supplementation, Glucosamine and Chondroitin sulfate supplementation and Supervised Exercise training in people with Knee Osteoarthritis, run by Foundation University Islamabad at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Osteoarthritis (OA) is one of the most common joint disorders, affecting not only the joints but also the surrounding muscles, which become weak. Resistance exercise reduces pain and improves function in patients with OA of the knee. Read more about this study

Who is it for?
Ages 40 to 70 years
Conditions the study is for
Knee Osteoarthritis
What is being tested?
Creatine Supplementation, Glucosamine and Chondroitin sulfate supplementation and Supervised Exercise training
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 sitePakistan
Study dates
10 Jun 2020to 6 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 40-70 years
  • Knee OA with history not less than three months.
  • Radiological evidences of grade III or less on Kellgren classification.
  • Knee pain on VNRS no more than 8/10

Who cannot join

  • Neuromuscular conditions that may lead to fatigue such as multiple Sclerosis
  • Signs of serious pathology (e.g., malignancy, inflammatory disorder, infection).
  • History of trauma or fractures in lower extremity.
  • Signs of lumbar radiculopathy or myelopathy.
  • History of knee surgery or replacement.
  • Patients on intra-articular steroid therapy within two months before the commencement of the study.
  • Impaired skin sensation.
  • Impaired renal function

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Foundation University Institute of Rehabilitation Sciences.

    Islamabad, Federal, 46000

Other trials in Pakistan

About this study

Osteoarthritis (OA) is one of the most common joint disorders, affecting not only the joints but also the surrounding muscles, which become weak. Resistance exercise reduces pain and improves function in patients with OA of the knee. Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used by patients with OA to reduce pain and thereby maintain the ability to perform daily activities. However, there is accumulating evidence for a negative effect of NSAIDs, thus many patients with OA are treated with dietary supplementations such as glucosamine and chondroitin sulfate, and some studies show a beneficial effects on cartilage and pain. However, their effect on OA symptoms and cartilage remains controversial. On the other hand creatine supplementation has also been observed to show promising effects when combined with resistance training exercise in the elderly, but the evidence is limited in terms of knee osteoarthritis. For this reason the purpose of this study is to determine the effects of creatine supplementation as compared to glucosamine/chondroitin sulfate in the management of knee osteoarthritis when combined with resistance training exercise.

Being tested
Creatine Supplementation, Glucosamine and Chondroitin sulfate supplementation, Supervised Exercise training, Home Exercise Program, Electrotherapy + Heating
Medical subject headings
Osteoarthritis, Knee

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Creatine SupplementationDietary supplement

    Creatine Supplementation 20g/day for 1 week followed by 5 g/day for 3 weeks

  • Glucosamine and Chondroitin sulfate supplementationDietary supplement

    Glucosamine 500 mg Chondroitin sulfate sodium 400mg 3/day

  • Supervised Exercise trainingOther

    Lower Extremity Resistance Exercise Training Treadmill walking 5-10 min for warm up Strength training: (80% of 8RM)

    3 times supervised exercise for 4 weeks leg press, leg extension, Sit to stand squat (mini squats) Stationary Cycling (Maximum Resistance as per patient tolerance till failure)

    3 sets 8 reps 10-15 s rep rest interval 1-2 min set rest interval

  • Home Exercise ProgramOther

    2 sets of 10 repetitions/day of

    AROM isolated knee extension and knee flexion Isometric isolated knee extension and knee flexion Isometric terminal knee extension Sit to stand squat Isometric knee terminal extension

  • Electrotherapy + HeatingProcedure or surgery

    Interferential Current therapy (2P), in combination with heating pad for 20 minutes

  • Joint MobilizationProcedure or surgery

    Tibio-femoral Anterior Glide Tibio-femoral Posterior Glide Patellofemoral Joint Mobilization

Study groups in NCT04665804
Study groupRoleWhat they receive
Experimental Group A (Creatine Supplementation)ExperimentalNot described
Receives: Dietary Supplement: Creatine Supplementation; Other: Supervised Exercise training; Other: Home Exercise Program; Procedure: Electrotherapy + Heating; Procedure: Joint Mobilization
Experimental Group B (Glucosamine and Chondroitin sulfate Supplementation)ExperimentalNot described
Receives: Dietary Supplement: Glucosamine and Chondroitin sulfate supplementation; Other: Supervised Exercise training; Other: Home Exercise Program; Procedure: Electrotherapy + Heating; Procedure: Joint Mobilization

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analogue Scale

    Visual Analogue Scale was used to measure pain scoring from 0-10 cm on a horizontal 10cm line. A greater score reflects higher pain intensity.

    Measured: 2 weeks

  2. Visual Analogue Scale

    Visual Analogue Scale was used to measure pain scoring from 0-10 cm on a horizontal 10cm line. A greater score reflects higher pain intensity.

    Measured: 4 weeks

  3. Knee Injury and Osteoarthritis Outcome Score

    Knee Injury and Osteoarthritis Outcome Score (KOOS) to measure physical function and quality of life. A greater score on Knee Injury and Osteoarthritis Outcome Score reflects good prognosis and outcome and a lower score shows poor prognosis and outcome. the score for Knee Injury and Osteoarthritis Outcome Score is reported in the form of percentage i.e. 0-100%.

    Measured: 2 weeks

  4. Knee Injury and Osteoarthritis Outcome Score

    Knee Injury and Osteoarthritis Outcome Score (KOOS) to measure physical function and quality of life. A greater score on Knee Injury and Osteoarthritis Outcome Score reflects good prognosis and outcome and a lower score shows poor prognosis and outcome. the score for Knee Injury and Osteoarthritis Outcome Score is reported in the form of percentage i.e. 0-100%.

    Measured: 4 weeks

  5. Knee Joint Range of Motion

    Knee Joint Range of Motion will be measured via goniometry. It is a continuous scale and a greater score reflects greater angular movement possible at the knee joint, which is measured in degrees.

    Measured: 2 weeks

  6. Knee Joint Range of Motion

    Knee Joint Range of Motion will be measured via goniometry. It is a continuous scale and a greater score reflects greater angular movement possible at the knee joint, which is measured in degrees.

    Measured: 4 weeks

  7. Body Composition

    Body Composition was measured via bioelectrical impedance analysis. A greater Phase angle reflects better cellular integrity and smaller phase angle reflects poorer cellular integrity.

    Measured: 2 weeks

  8. Body Composition

    Body Composition was measured via bioelectrical impedance analysis. A greater Phase angle reflects better cellular integrity and smaller phase angle reflects poorer cellular integrity.

    Measured: 4 weeks

  9. Fall risk

    Fall risk will be measured via Biodex balance system, and greater score reflects greater fall risk and poorer outcome.

    Measured: 2 weeks

  10. Fall risk

    Fall risk will be measured via Biodex balance system, and greater score reflects greater fall risk and poorer outcome.

    Measured: 4 weeks

  11. 5 repetition sit to stand test

    Time will be measured to perform 5 repetitions of sit to stand activity. Lesser time means a better score.

    Measured: 2 weeks

  12. 5 repetition sit to stand test

    Time will be measured to perform 5 repetitions of sit to stand activity. Lesser time means a better score.

    Measured: 4 weeks

  13. Modified sphygmomanometer dynamometry

    Modified sphygmomanometer dynamometry was used to measure muscle strength. Greater score will reflect greater muscle strength. The unit of Modified sphygmomanometer dynamometry used will be mmHg (millimeter of mercury).

    Measured: 2 weeks

  14. Modified sphygmomanometer dynamometry

    Modified sphygmomanometer dynamometry was used to measure muscle strength. Greater score will reflect greater muscle strength. The unit of Modified sphygmomanometer dynamometry used will be mmHg (millimeter of mercury).

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Dec 2020
  2. Study start10 Jun 2020
  3. Primary completion6 Dec 2020
  4. Study completion6 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04665804
Sponsor's protocol ID
FUI/CTR/2020/12
Status last verified
Dec 2020
First submitted
7 Dec 2020
Last updated
14 Dec 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Creatine Supplementation, Glucosamine and Chondroitin sulfate supplementation and Supervised Exercise training in people with Knee Osteoarthritis, run by Foundation University Islamabad at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analogue Scale (time frame: 2 weeks). The study lists 14 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Dec 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in